PORTOLA PHARMACEUTICALS INC Income Statement

Ask AI

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2019 12 months to Dec 31, 2019	FY2018 12 months to Dec 31, 2018	FY2017 12 months to Dec 31, 2017	FY2016 12 months to Dec 31, 2016	FY2015 12 months to Dec 31, 2015
Collaboration and license revenue
Revenues
Product Revenue, net
Collaboration and license revenue
Total revenues
Operating expenses:
Cost of sales
Research and development
Selling, general and administrative
Total operating expenses
Loss from operations
Interest and other income (expense), net
Interest expense
Loss before taxes
Income tax benefit
Net loss
Net loss (income) attributable to noncontrolling interest
Net loss attributable to Portola
Net loss per share attributable to Portola common stockholders:
Basic and diluted (in dollars per share)
Shares used to compute net loss per share attributable to Portola common stockholders:
Basic and diluted (in shares)

Comments